244 related articles for article (PubMed ID: 15869845)
1. Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM).
Lawrinson P; Copeland J; Indig D
Drug Alcohol Depend; 2005 Oct; 80(1):125-33. PubMed ID: 15869845
[TBL] [Abstract][Full Text] [Related]
2. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
[TBL] [Abstract][Full Text] [Related]
3. Development of a brief treatment instrument for routine clinical use with methadone maintenance treatment clients: the methadone treatment index.
Deering DE; Sellman JD; Adamson SJ; Horn J; Frampton CM
Subst Use Misuse; 2008; 43(11):1666-80. PubMed ID: 18752159
[TBL] [Abstract][Full Text] [Related]
4. Test-retest reliability of self-reported drug treatment variables.
Edwards JW; Fisher DG; Johnson ME; Reynolds GL; Redpath DP
J Subst Abuse Treat; 2007 Jul; 33(1):7-11. PubMed ID: 17588484
[TBL] [Abstract][Full Text] [Related]
5. Impact of case management on rural women's quality of life and substance use.
Passey M; Sheldrake M; Leitch K; Gilmore V
Rural Remote Health; 2007; 7(3):710. PubMed ID: 17683243
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
7. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
8. The Alcohol Treatment Outcome Measure (ATOM): a new clinical tool for standardising outcome measurement for alcohol treatment.
Simpson M; Lawrinson P; Copeland J; Gates P
Addict Behav; 2009 Jan; 34(1):121-4. PubMed ID: 18945550
[TBL] [Abstract][Full Text] [Related]
9. Development of the Treatment Outcomes Profile.
Marsden J; Farrell M; Bradbury C; Dale-Perera A; Eastwood B; Roxburgh M; Taylor S
Addiction; 2008 Sep; 103(9):1450-60. PubMed ID: 18783500
[TBL] [Abstract][Full Text] [Related]
10. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
11. The substances and choices scale (SACS)--the development and testing of a new alcohol and other drug screening and outcome measurement instrument for young people.
Christie G; Marsh R; Sheridan J; Wheeler A; Suaalii-Sauni T; Black S; Butler R
Addiction; 2007 Sep; 102(9):1390-8. PubMed ID: 17645425
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Winstock AR; Lea T; Sheridan J
Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
[TBL] [Abstract][Full Text] [Related]
13. Development and preliminary testing of the General 5-Spectrum Measure (GSM-V).
Rucci P; Frank E; Fagiolini A; Kupfer DJ; Shear MK; Dell'Osso L; Banti S; Mauri M; Grochocinski VJ; Maser JD; Endicott J; Cassano GB
Depress Anxiety; 2003; 18(3):109-17. PubMed ID: 14625875
[TBL] [Abstract][Full Text] [Related]
14. A Psychometric evaluation of the German version of the 'Health of the Nation Outcome Scales, HoNOS-D': on the feasibility and reliability of clinician-performed measurements of severity in patients with mental disorders.
Andreas S; Harfst T; Dirmaier J; Kawski S; Koch U; Schulz H
Psychopathology; 2007; 40(2):116-25. PubMed ID: 17215598
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of the effectiveness of [corrected] auditory rehabilitation scale.
Yueh B; McDowell JA; Collins M; Souza PE; Loovis CF; Deyo RA
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):851-6. PubMed ID: 16230585
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes.
Greig RL; Baker A; Lewin TJ; Webster RA; Carr VJ
Drug Alcohol Rev; 2006 May; 25(3):249-58. PubMed ID: 16753649
[TBL] [Abstract][Full Text] [Related]
17. A brief measure of vocational activity and community participation: development and reliability of the Activity and Participation Questionnaire.
Stewart G; Sara G; Harris M; Waghorn G; Hall A; Sivarajasingam S; Gladman B; Mowry B
Aust N Z J Psychiatry; 2010 Mar; 44(3):258-66. PubMed ID: 20050719
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA).
Pierucci-Lagha A; Gelernter J; Feinn R; Cubells JF; Pearson D; Pollastri A; Farrer L; Kranzler HR
Drug Alcohol Depend; 2005 Dec; 80(3):303-12. PubMed ID: 15896927
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine injection in Melbourne, Australia--an update.
Aitken CK; Higgs PG; Hellard ME
Drug Alcohol Rev; 2008 Mar; 27(2):197-9. PubMed ID: 18264882
[TBL] [Abstract][Full Text] [Related]
20. Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: the ICIQ-VS.
Price N; Jackson SR; Avery K; Brookes ST; Abrams P
BJOG; 2006 Jun; 113(6):700-12. PubMed ID: 16709214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
